Cargando…
Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types
SIMPLE SUMMARY: Ample evidence exists connecting dNTP pool dysregulation to cancer and genomic instability. SAMHD1, the unique dNTP triphosphohydrolase described in humans, has been proposed to play a key role in hematological cancers, although its value in advanced solid tumors has not yet been exp...
Autores principales: | Felip, Eudald, Gutiérrez-Chamorro, Lucía, Gómez, Maica, Garcia-Vidal, Edurne, Romeo, Margarita, Morán, Teresa, Layos, Laura, Pérez-Roca, Laia, Riveira-Muñoz, Eva, Clotet, Bonaventura, Fernandez, Pedro Luis, Mesía, Ricard, Martínez-Cardús, Anna, Ballana, Ester, Margelí, Mireia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833711/ https://www.ncbi.nlm.nih.gov/pubmed/35158911 http://dx.doi.org/10.3390/cancers14030641 |
Ejemplares similares
-
Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy
por: Castellví, Marc, et al.
Publicado: (2020) -
SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis
por: Gutiérrez-Chamorro, Lucía, et al.
Publicado: (2023) -
The Deoxynucleoside Triphosphate Triphosphohydrolase Activity of SAMHD1 Protein Contributes to the Mitochondrial DNA Depletion Associated with Genetic Deficiency of Deoxyguanosine Kinase
por: Franzolin, Elisa, et al.
Publicado: (2015) -
Erratum: Castellví, M. et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 2020, 12, 713
por: Castellví, Marc, et al.
Publicado: (2020) -
Quantitation of cellular deoxynucleoside triphosphates
por: Ferraro, Paola, et al.
Publicado: (2010)